503 Intel

State Board Intelligence for 503A & 503B Pharmacies

Every board action that touches your compounding license, every weekday.

503 Intel tracks all 50 state boards of pharmacy, DC, FDA, DEA and the courts. Each item tells you what happened, why it matters to a compounder, and where to read the source.

Sign in with your work email for 14 days of full access. No card needed. Headlines stay free after that.

51State and DC boards watched
0Actions, last 90 days
0High impact, last 90 days
0Meetings and deadlines ahead

What a subscription gets you

Written for owners, pharmacists in charge and compliance leads at 503A pharmacies and 503B outsourcing facilities.

Board actions, daily

Votes, final and proposed rules, emergency rules, guidance and discipline against compounders, checked every weekday.

Why it matters

Every item ends with one plain line on what a compounder should do or watch, so you can act without reading the whole docket.

Source on every item

Each entry links to the board notice, register filing, FDA letter or court opinion it came from.

Your licensed states

Pick the states you ship into and filter the feed to them. Federal actions always show.

Meeting and deadline calendar

Upcoming board meetings, rule hearings and comment deadlines with agendas as boards post them.

The topics that move licenses

GLP-1s, peptides and Category 2 bulks, nonresident licensing, USP 797/800, office use, telehealth, prescriber authority and 503B rules.

How access works

Sign in with your email and you get everything for 14 days. No card, no sales call. Plan details arrive in your welcome email.

After the trial

  • Keep full access with a monthly or annual plan, started from your feed
  • Or keep reading every headline, with state, date and impact level, at no cost
  • Cancel anytime from your billing page
Sign in

Questions

What does 503 Intel cover?

All 50 state boards of pharmacy plus DC, and the federal actions that drive them: FDA compounding guidance and warning letters, the 503A bulks list and Category 2 changes, DEA telemedicine rules, NABP programs and court rulings.

How is it researched?

Items are gathered each weekday with AI-assisted research across board sites, state registers, FDA and the courts. Every item links to its source so you can confirm the details yourself.

Is this legal advice?

No. 503 Intel summarizes public actions. Confirm details with the source and your counsel before acting.

What happens when the trial ends?

You keep every headline. To keep summaries, sources and the meeting calendar, pick a monthly or annual plan from your feed. We email plan details when your trial starts and again before it ends. If you subscribe during the trial, the first charge waits until the trial is over.

Can my whole team use one subscription?

Each subscription is one sign-in. Email us for team pricing.

How do I cancel?

Open the feed, choose Manage billing, and cancel. You keep access through the end of the period you paid for.